PETER RICHARDSON to Cost-Benefit Analysis
This is a "connection" page, showing publications PETER RICHARDSON has written about Cost-Benefit Analysis.
Connection Strength
0.010
-
Prevention of complicated ulcer disease among chronic users of nonsteroidal anti-inflammatory drugs: the use of a nomogram in cost-effectiveness analysis. Arch Intern Med. 2002 Oct 14; 162(18):2105-10.
Score: 0.010